June 14, 2016 — Charity Navigator, America’s largest independent charity evaluator, has again awarded the Foundation for the National Institutes of Health (FNIH) its highest, 4-star rating—this time with a perfect (100%) score.
May 23, 2016 — This morning, the Democratic Staff of the Committee on Energy and Commerce issued a report on the Sports and Health Research Program (SHRP), a partnership among the National Institutes of Health (NIH), National Football League (NFL) and the Foundation for the National Institutes of Health (FNIH). The following is the FNIH’s response to the report.
May 3, 2016 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium is launching a research partnership to determine whether liquid biopsies can be used instead of traditional solid tumor biopsies for diagnosing and monitoring metastatic colorectal cancer. According to the American Cancer Society, metastatic colorectal cancer is the third leading cause of cancer death in the United States.
March 24, 2016— The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a 4-year project to transform our ability to characterize risk for developing cardiovascular disease. The project is poised to improve identification and care of at-risk patients through a comprehensive investigation that will measure novel biomarkers in a national study consisting of more than 25,000 samples.
March 8, 2016— The Foundation for the National Institutes of Health (FNIH) is honored to announce that long-standing FNIH board member Mrs. Lily Safra has generously donated more than $675,000 to continue her ongoing support of advancing biomedical research and caring for NIH patients and their families. The donation, made possible from the auction Jewels for Hope: The Collection of Mrs. Lily Safra, will further drive the missions of the Edmond J. Safra Family Lodge and the Charles A. Sanders Legacy Fund.
Through the Sports and Health Research Program (SHRP) —a partnership among the National Institutes of Health (NIH), the National Football League (NFL), and the Foundation for the National Institutes of Health (FNIH)—multiple studies have been and will continue to be funded to examine traumatic brain injury in athletes. The NFL funding commitment to SHRP remains intact.
The Foundation for the National Institutes of Health (FNIH) has awarded a 4-year grant award in the amount of $4 million to the European Molecular Biology Laboratory — European Bioinformatics Institute (EMBL‐EBI), the University of Oxford, and the Broad Institute of the Massachusetts Institute of Technology and Harvard University to support the buildout of a European arm of the Type 2 Diabetes (T2D) Knowledge Portal. The award is part of the Accelerating Medicines Partnership Type 2 Diabetes (AMP T2D) initiative.
In a recent op-ed in the North Carolina News & Observer, Dr. Charles Sanders, FNIH Board Chairman, expresses his views on the importance of continued NIH funding in the state. He cites that benefits of NIH support include important medical research that could lead to discovering new cures for vexing diseases as well as a contribution to economic activity and the creation of new research jobs.
Earlier this week, the FNIH held a dinner for the FNIH Board of Directors and other distinguished guests centered on the topic of cancer immunotherapy with members from the scientific community, the advocacy community, industry and government.
